Thomsen RW, Nicolaisen SK, Hasvold P, et al. Elevated potassium levels in patients with congestive heart failure: occurrence, risk factors, and clinical outcomes: a Danish population-based cohort study. J Am Heart Assoc. 2018;7(11): e008912. https://doi.org/10.1161/JAHA.118.008912.
Article CAS PubMed PubMed Central Google Scholar
Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21. https://doi.org/10.1159/000479802.
Article CAS PubMed Google Scholar
Núñez J, Bayés-Genís A, Zannad F, et al. Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation. 2018;137(13):1320–30. https://doi.org/10.1161/CIRCULATIONAHA.117.030576.
Article CAS PubMed Google Scholar
Ferreira JP, Rossignol P, Machu JL, et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017;19:1284–93. https://doi.org/10.1002/ejhf.90.
Article CAS PubMed Google Scholar
Savarese G, Carrero JJ, Pitt B, et al. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018;20:1326–34. https://doi.org/10.1002/ejhf.1182.
Article CAS PubMed Google Scholar
Epstein M, Reaven NL, Funk SE, McGaughey KJ, Oestreicher N, Knispel J. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Managed Care. 2015;21:S212–20.
Rosano GMC, Tamargo J, Kjeldsen KP, et al. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. European Hear J - Cardiovasc Pharmacother. 2018;4:180–8. https://doi.org/10.1093/ehjcvp/pvy015.
McLean RM, Wang NX. Potassium. Adv Food Nutr Res. 2021;96:89–121. https://doi.org/10.1016/bs.afnr.2021.02.013.
Article CAS PubMed Google Scholar
Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7:75–84. https://doi.org/10.1038/nrneph.2010.175.
Article CAS PubMed Google Scholar
Palmer BF, Carrero JJ, Clegg DJ, et al. Clinical management of hyperkalemia. Mayo Clin Proc. 2021;96:744–62. https://doi.org/10.1016/j.mayocp.2020.06.014.
Article CAS PubMed Google Scholar
Ewart HS, Klip A. Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995;269(2 Pt 1):C295-311. https://doi.org/10.1152/ajpcell.1995.269.2.C295.
Article CAS PubMed Google Scholar
Allon M, Shanklin N. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease. Kidney Int. 1991;40:1103–9. https://doi.org/10.1038/ki.1991.321.
Article CAS PubMed Google Scholar
Mihailidou AS, Buhagiar KA, Rasmussen HH. Na+ influx and Na(+)-K+ pump activation during short-term exposure of cardiac myocytes to aldosterone. Am J Physiol. 1998;274:C175–81. https://doi.org/10.1152/ajpcell.1998.274.1.C175.
Article CAS PubMed Google Scholar
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2022;24:4–131. https://doi.org/10.1093/eurheartj/ehab368.
Article CAS PubMed Google Scholar
Ranjitkar P, Greene DN, Baird GS, Hoofnagle AN, Mathias PC. Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia. Clin Biochem. 2017;50:663–9. https://doi.org/10.1016/j.clinbiochem.2017.03.007.
Roccaforte V, Daves M, Alfreijat A, et al. Spurious elevation of serum potassium concentration measured in samples with thrombocytosis. Diagnosis (Berl). 2016;3:71–4. https://doi.org/10.1515/dx-2016-0008.
Liu S, Zhang L, Weng H, Yang F, Jin H, Fan F, Zheng X, Yang H, Li H, Zhang Y, Li J. Association between average plasma potassium levels and 30-day mortality during hospitalization in patients with COVID-19 in Wuhan. China Int J Med Sci. 2021Jan 1;18(3):736–43. https://doi.org/10.7150/ijms.50965.
Article CAS PubMed Google Scholar
Pannall P, Rossi A. Potassium levels in serum and plasma. Clin Chim Acta. 1970;30(1):218–20. https://doi.org/10.1016/0009-8981(70)90211-1.
Article CAS PubMed Google Scholar
Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft Petersen P, Simonsson P, Steensland H, Uldall A. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest. 2004;64:271–84.
Article CAS PubMed Google Scholar
Cooper LB, Savarese G, Carrero JJ, et al. Clinical and research implications of serum versus plasma potassium measurements. Eur J Heart Fail. 2019;21(4):536–7. https://doi.org/10.1002/ejhf.1371.
Seamark D, Backhouse S, Barber P, Hichens J, Salzmann M, Powell R. Transport and temperature effects on measurement of serum and plasma potassium. J R Soc Med. 1999;92(7):339–41. https://doi.org/10.1177/014107689909200703).
Article CAS PubMed PubMed Central Google Scholar
Nijsten MW, de Smet BJ, Dofferhoff AS. Pseudohyperkalemia and platelet counts. N Engl J Med. 1991;325(15):1107. https://doi.org/10.1056/NEJM199110103251515).
Article CAS PubMed Google Scholar
Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem. 1996;42:813–6.
Article CAS PubMed Google Scholar
Tromp J, van der Meer P. Hyperkalaemia: aetiology, epidemiology, and clinical significance. Eur Heart J Suppl. 2019;21(Suppl A):A6–11. https://doi.org/10.1093/eurheartj/suy028.
Article CAS PubMed PubMed Central Google Scholar
Humphrey T, Davids MR, Chothia MY, Pecoits-Filho R, Pollock C, James G. How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies. Clin Kidney J. 2022;15(4):727–37. https://doi.org/10.1093/ckj/sfab243.
Martín-Pérez M, Ruigómez A, Michel A, García Rodríguez AL. Impact of hyperkalaemia definition on incidence assessment implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care. Bmc Fam Pract. 2016;17:51. https://doi.org/10.1186/s12875-016-0448-5.
Article CAS PubMed PubMed Central Google Scholar
Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012;15(109):1510–3. https://doi.org/10.1016/j.amjcard.2012.01.367.
Rossignol P, Lainscak M, Crespo-Leiro MG, et al. Unravelling the interplay between hyperkalaemia, renin-angiotensin aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORPHeart Failure Long-Term Registry. Eur J Heart Fail. 2020;22:1378–89. https://doi.org/10.1002/ejhf.1793.
Article CAS PubMed Google Scholar
Fleet JL, Shariff SZ, Gandhi S, Weir MA, Jain AK, Garg AX. Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission. BMJ Open. 2012;2(6):e002011. https://doi.org/10.1136/bmjopen-2012-002011.
Article PubMed PubMed Central Google Scholar
Conway R, Creagh D, Byrne DG, O’Riordan D, Silke B. Serum potassium levels as an outcome determinant in acute medical admissions. Clin Med (Lond). 2015;15:239–43. https://doi.org/10.7861/clinmedicine.15-3-239.
Nilsson E, Gasparini A, Ärnlöv J, et al. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J Cardiol. 2017;245:277–84. https://doi.org/10.1016/j.ijcard.2017.07.035.
Chang AR, Sang Y, Leddy J, et al. Antihypertensive medications and the prevalence of hyperkalemia in a large health system. Hypertension. 2016Jun;67(6):1181–8. https://doi.org/10.1161/HYPERTENSIONAHA.116.07363.
Article CAS PubMed Google Scholar
McMurray JJV, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767–71. https://doi.org/10.1016/S0140-6736(03)14283-3.
Article CAS PubMed Google Scholar
Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456–67.
留言 (0)